Epoetin alfa: current and future indications and nursing implications.

Area of Science:

• Oncology
• Hematology
• Pharmacology

Background:

• Cancer-related anemia significantly impacts patient quality of life (QOL) and treatment tolerance.
• Fatigue and decreased QOL are common burdens for patients undergoing chemotherapy.
• Optimizing hemoglobin levels is crucial for managing anemia symptoms and survival time.

Purpose of the Study:

• To review the efficacy and safety of epoetin alfa for cancer-related anemia.
• To explore new dosing strategies and potential applications of epoetin alfa.
• To emphasize the role of oncology nurses in managing anemia and improving patient QOL.

Main Methods:

• Review of preclinical and pilot clinical studies on epoetin alfa.
• Analysis of data regarding weekly administration of epoetin alfa.
• Assessment of potential benefits beyond anemia management, such as cognitive function.

Main Results:

• Epoetin alfa can be safely and effectively administered weekly for anemia in non-cancer patients.
• Evidence suggests epoetin alfa may improve cognitive function.
• Oncology nurses play a vital role in patient QOL through anemia management.

Conclusions:

• Weekly epoetin alfa presents a viable treatment option for certain anemic populations.
• Further research into epoetin alfa's role in cognitive enhancement is warranted.
• Enhanced awareness of epoetin alfa's evolving applications is essential for oncology nursing practice.